Novel DNA Biosensing Platform for Detecting HIV Integrase for Highly Sensitive and Quantitative HIV Detection, Diagnosis, and Therapeutic Monitoring
Open Access
- 28 May 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (23) , 25042-25053
Abstract
Straightforward, sensitive, and specific human immunodeficiency virus (HIV) assays are urgently needed. The creation of a point-of-care (POC) device for decentralized diagnostics has the potential to significantly reduce the time to treatment, especially for infectious diseases. Notably, however, many POC solutions proposed to date fall short of meeting the ASSURED guidelines, which are crucial for effective deployment in the field. Herein, we developed a DNA biosensor platform for the specific and quantitative detection of HIV. The platform contains a rolling circle amplification (RCA)-based DNA biosensor and a portable fluorescence detector, in which HIV-encoded integrase (IN) enzyme activity is used as a biomarker to achieve HIV-specific detection. The cleavage and integration reaction of IN on the sensor surface and RCA are combined in this detection platform to perform detection signal cascade amplification, ultimately achieving a detection limit of 0.125 CFU/μL of HIV particles. Moreover, the DNA sensor system exhibited high sensitivity and accuracy for detecting HIV in clinical samples, suggesting that it has potential for application in clinical settings to detect retroviruses other than HIV. In addition, quantitative detection based on this biosensing platform was significantly correlated with the CD4+ lymphocytes count, which can provide guidance for antiretroviral therapy and which affects long-term death risk assessment in HIV patients. Therefore, this DNA biosensing platform based on IN activity is expected to be useful for rapid HIV testing, diagnosis, and treatment monitoring, enabling the development of new POC diagnostic tests and will thus be highly valuable for developing HIV prevention strategies and effective treatments.Keywords
Funding Information
- Science and Technology Foundation of Shenzhen City (GJHZ20190821161420866, JCYJ20190807144609346)
- National Natural Science Foundation of China (82001755)
- Natural Science Foundation of Guangdong Province (2020A1515110521)
This publication has 37 references indexed in Scilit:
- Enzyme-catalyzed electrochemical aptasensor for ultrasensitive detection of soluble PD-L1 in breast cancer based on decorated covalent organic frameworks and carbon nanotubesAnalytica Chimica Acta, 2023
- Development of antibody-aptamer sandwich-like immunosensor based on RCA and Nicked-PAM CRISPR/Cas12a system for the ultra-sensitive detection of a biomarkerAnalytica Chimica Acta, 2023
- DNA tetrahedron-besieged primer and DNAzyme-activated programmatic RCA for low-background electrochemical detection of ochratoxin AAnalytica Chimica Acta, 2023
- Engineering light-initiated afterglow lateral flow immunoassay for infectious disease diagnosticsBiosensors and Bioelectronics, 2022
- Protein sensors combining both on-and-off model for antibody homogeneous assayBiosensors and Bioelectronics, 2022
- Sub-picomolar lateral flow antigen detection with two-wavelength imaging of composite nanoparticlesBiosensors and Bioelectronics, 2022
- A DNA Nanoflower‐Assisted Separation‐Free Nucleic Acid Detection Platform with a Commercial Pregnancy Test StripAngewandte Chemie International Edition, 2021
- Developing a dual-RCA microfluidic platform for sensitive E. coli O157:H7 whole-cell detectionsAnalytica Chimica Acta, 2020
- Self-assembled fluorescent Ce(Ⅲ) coordination polymer as ratiometric probe for HIV antigen detectionAnalytica Chimica Acta, 2019
- A colloidal gold probe-based silver enhancement immunochromatographic assay for the rapid detection of abrin-aBiosensors and Bioelectronics, 2011